HuGE Literature Finder
Records 1-30
|
Association of imputed prostate cancer transcriptome with disease risk reveals novel mechanisms.
Nature communications 2019 Jul 10 (1): 3107. Emami Nima C, Kachuri Linda, Meyers Travis J, Das Rajdeep, Hoffman Joshua D, Hoffmann Thomas J, Hu Donglei, Shan Jun, Feng Felix Y, Ziv Elad, Van Den Eeden Stephen K, Witte John |
|
Genomic analysis of Korean patients with advanced prostate cancer by use of a comprehensive next-generation sequencing panel and low-coverage, whole-genome sequencing.
Investigative and clinical urology 2019 Jul 60 (4): 227-234. Kang Minyong, Cho Eunhae, Jang Jahyun, Lee Junnam, Jeon Youngjoo, Jeong Byong Chang, Seo Seong Il, Jeon Seong Soo, Lee Hyun Moo, Choi Han Yong, Jeon Hwang Gy |
|
Studying Copy Number Variations in Cell-Free DNA: The Example of AR in Prostate Cancer.
Methods in molecular biology (Clifton, N.J.) 2019 1909 95-103. Salvi Samanta, Casadio Valenti |
|
Mutational Profile of Aggressive, Localised Prostate Cancer from African Caribbean Men Versus European Ancestry Men.
European urology 2018 Sep . Tonon Laurie, Fromont Gaëlle, Boyault Sandrine, Thomas Emilie, Ferrari Anthony, Sertier Anne-Sophie, Kielbassa Janice, Le Texier Vincent, Kamoun Aurélie, Elarouci Nabila, Irani Jacques, Multigner Luc, Gut Ivo Glynne, Gut Marta, Blanchet Pascal, De Reynies Aurélien, Cancel-Tassin Géraldine, Viari Alain, Cussenot Olivi |
|
Association of HSD3B1 Genotype With Response to Androgen-Deprivation Therapy for Biochemical Recurrence After Radiotherapy for Localized Prostate Cancer.
JAMA oncology 2017 Oct . Hearn Jason W D, Xie Wanling, Nakabayashi Mari, Almassi Nima, Reichard Chad A, Pomerantz Mark, Kantoff Philip W, Sharifi Ni |
|
Association between polymorphic CAG repeat lengths in the androgen receptor gene and susceptibility to prostate cancer: A systematic review and meta-analysis.
Medicine 2017 Jun 96 (25): e7258. Qin Zhiqiang, Li Xiao, Han Peng, Zheng Yuxiao, Liu Hanyu, Tang Jingyuan, Yang Chengdi, Zhang Jianzhong, Wang Kunpeng, Qi Xiaokang, Tang Min, Wang Wei, Zhang W |
|
Lower prostate cancer risk in Swedish men with the androgen receptor E213 A-allele.
Cancer causes & control : CCC 2017 Feb . Bentmar Holgersson Magdalena, Ruhayel Yasir, Karlsson Magnus, Giwercman Aleksander, Bjartell Anders, Ohlsson Claes, Mellström Dan, Ljunggren Östen, Haghsheno Mohammad-Ali, Damber Jan-Erik, Lundberg Giwercman Yvon |
|
Androgen receptor gene polymorphisms and risk of prostate cancer: a meta-analysis.
Scientific reports 2017 Jan 7 40554. Weng Hong, Li Sheng, Huang Jing-Yu, He Zi-Qi, Meng Xiang-Yu, Cao Yue, Fang Cheng, Zeng Xian-T |
|
Genotyping the High Altitude Mestizo Ecuadorian Population Affected with Prostate Cancer.
BioMed research international 2017 2017 3507671. López-Cortés Andrés, Cabrera-Andrade Alejandro, Salazar-Ruales Carolina, Zambrano Ana Karina, Guerrero Santiago, Guevara Patricia, Leone Paola E, Paz-Y-Miño Cés |
|
Androgen receptor CAG polymorphism and sporadic and early-onset prostate cancer among Mexican men.
Journal of human genetics 2016 Sep 61 (9): 781-6. Gómez Rocío, Torres-Sánchez Luisa, Camacho-Mejorado Rafael, Burguete-García Ana I, Vázquez-Salas Ruth Argelia, Martínez-Nava Gabriela A, Santana Carla, Noris Gi |
|
A genetic variation of SOD2 does not determine duration of response to androgen deprivation therapy for prostate cancer.
The Prostate 2016 Jun . Xie Wanling, Drouin Sarah, Nakabayashi Mari, Pomerantz Mark, Lee Gwo-Shu Mary, Kantoff Philip W, Sharifi Ni |
|
Positive association of the androgen receptor CAG repeat length polymorphism with the risk of prostate cancer.
Molecular medicine reports 2016 Jun . Paz-Y-Miño César, Robles Paulo, Salazar Carolina, Leone Paola E, García-Cárdenas Jennyfer M, Naranjo Manuel, López-Cortés Andr |
|
Trinucleotide repeat length in the first exon of the androgen receptor gene may be associated with prostate carcinogenesis and facilitate prediction of prostate cancer aggressiveness.
Polskie Archiwum Medycyny Wewnetrznej 2016 Feb . Lemi?ski Artur, Bi?czak-Kuleta Agnieszka, Kaczmarczyk Mariusz, Skonieczna-?ydecka Karolina, Ciechanowicz Andrzej, S?ojewski Marc |
|
Increased androgen receptor gene copy number is associated with TMPRSS2-ERG rearrangement in prostatic small cell carcinoma.
Molecular carcinogenesis 2015 Sep 54 (9): 900-7. Wang Lisha, Williamson Sean R, Zhang Shaobo, Huang Jiaoti, Montironi Rodolfo, Davison Darrell D, Wang Mingsheng, Yao Jorge L, Lopez-Beltran Antonio, Osunkoya Adeboye O, MacLennan Gregory T, Baldridge Lee Ann, Du Xiang, Cheng Lia |
|
Androgenetic alopecia and polymorphism of the androgen receptor gene (SNP rs6152) in patients with benign prostate hyperplasia or prostate cancer.
Journal of the European Academy of Dermatology and Venereology : JEADV 2015 Jan 29 (1): 91-6. Kucerova R, Bienova M, Kral M, Bouchal J, Trtkova K S, Burdova A, Student V, Kolar |
|
Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG-positive prostate cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2014 Oct 23 (10): 2027-31. Yoo Sun, Pettersson Andreas, Jordahl Kristina M, Lis Rosina T, Lindstrom Sara, Meisner Allison, Nuttall Elizabeth J, Stack Edward C, Stampfer Meir J, Kraft Peter, Brown Myles, Loda Massimo, Giovannucci Edward L, Kantoff Philip W, Mucci Lorelei |
|
Androgen receptor CAG repeat length and TMPRSS2:ETS prostate cancer risk: results From the Prostate Cancer Prevention Trial.
Urology 2014 Jul 84 (1): 127-31. Figg William D, Chau Cindy H, Price Douglas K, Till Cathee, Goodman Phyllis J, Cho Yonggon, Varella-Garcia Marileila, Reichardt Juergen K V, Tangen Catherine M, Leach Robin J, van Bokhoven Adrie, Thompson Ian M, Lucia M Sco |
|
Correlation study between the polymorphism of repetitive sequence in gene CAG of androgen receptor and the occurrence and progression of prostate cancer.
Asian Pacific journal of tropical medicine 2014 Apr 7 (4): 301-4. Zhai Xiao-Lei, Qu Xiao-Wei, Guo Liang, Ha Qian- |
|
Direct detection of the AR-E211 G?>?A gene polymorphism from blood and tissue samples without DNA isolation.
Pathology oncology research : POR 2014 Apr 20 (2): 223-7. Reptova Silvie, Trtkova Katerina Smesny, Kolar Zden |
|
Contribution of allelic variability in prostate specific antigen (PSA) & androgen receptor (AR) genes to serum PSA levels in men with prostate cancer.
The Indian journal of medical research 2014 Mar 139 (3): 371-8. Chavan Sushant V, Maitra Anurupa, Roy Nobhojit, Chavan Padma |
|
Androgen receptor mutations and polymorphisms in African American prostate cancer.
International journal of biological sciences 2014 10 (6): 643-51. Koochekpour Shahriar, Buckles Erick, Shourideh Mojgan, Hu SiYi, Chandra Dhyan, Zabaleta Jovanny, Attwood Kristoph |
|
The place of androgen receptor gene mutation analysis in the molecular diagnosis of prostate cancer and genotype-phenotype relationship.
Turkish journal of medical sciences 2014 44 (2): 261-6. Kizilay Fuat, Kalemci Mustafa Serdar, ?im?ir Adnan, Turna Burak, Nazli Oktay, Berdeli Af |
|
Association between CAG repeat polymorphisms and the risk of prostate cancer: a meta-analysis by race, study design and the number of (CAG)n repeat polymorphisms.
International journal of molecular medicine 2013 Nov 32 (5): 1195-203. Sun Jun-Hyun, Lee Sang- |
|
Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer.
Medical oncology (Northwood, London, England) 2013 Mar 30 (1): 1. Monteiro C, Sousa MV, Ribeiro R, Maurício J, Fraga A, Medeiros R |
|
Molecular markers in sex hormone pathway genes associated with the efficacy of androgen-deprivation therapy for prostate cancer.
PloS one 2013 8 (1): 1. Yu CC, Huang SP, Lee YC, Huang CY, Liu CC, Hour TC, Huang CN, You BJ, Chang TY, Huang CH, Bao BY |
|
Androgen receptor GGC polymorphism and testosterone levels associated with high risk of prostate cancer and benign prostatic hyperplasia.
Molecular biology reports 2012 Nov . Biolchi V, Neto BS, Pianta DB, Koff WJ, Berger M, Brum IS |
|
Androgen metabolism and JAK/STAT pathway genes and prostate cancer risk.
Cancer epidemiology 2012 Aug 36 (4): 347-53. Kwon Erika M, Holt Sarah K, Fu Rong, Kolb Suzanne, Williams Gabrielle, Stanford Janet L, Ostrander Elaine |
|
Association of androgen receptor, prostate-specific antigen, and CYP19 gene polymorphisms with prostate carcinoma and benign prostatic hyperplasia in a north Indian population.
Genetic testing and molecular biomarkers 2012 Aug 16 (8): 835-40. Soni Abha, Bansal Anju, Mishra Ashwani Kumar, Batra Jyotsna, Singh Laishram Chandreshwor, Chakraborty Anurupa, Yadav Dhirendra Singh, Mohanty Nayan K, Saxena Suni |
|
Relationship of obesity, androgen receptor genotypes and biochemical failure after radical prostatectomy.
The Prostate 2012 Jun 72 (9): 984-90. Zeigler-Johnson Charnita, Weber Anita, Spangler Elaine, Panossian Saarene, Rebbeck Timothy R, Malkowicz S Bru |
|
The CAG repeat polymorphism of androgen receptor gene and prostate cancer: a meta-analysis.
Molecular biology reports 2012 Mar 39 (3): 2615-24. Gu Mingliang, Dong Xiaoqun, Zhang Xuezhi, Niu Wenqu |
|
Evaluation of the effects of androgen receptor gene trinucleotide repeats and prostate-specific antigen gene polymorphisms on prostate cancer.
Genetics and molecular research : GMR 2012 11 (2): 1424-32. Alptekin D, Izmirli M, Bayazit Y, Luleyap H U, Yilmaz M B, Soyupak B, Erkoc M A, Tansug |
|
Germline CAG repeat length of the androgen receptor and time to progression in patients with prostate cancer treated with androgen deprivation therapy.
BJU international 2011 Oct 108 (7): 1086-91. Misra Dipika, Xie Wanling, Regan Meredith M, Ross Robert W, Lee Gwo-shu, Germain Doris, Kantoff Philip W, Oh William |
|
Genetic polymorphisms of CYP17A1, vitamin D receptor and androgen receptor in Italian heredo-familial and sporadic prostate cancers.
Cancer epidemiology 2011 Aug 35 (4): e18-24. Risio Mauro, Venesio Tiziana, Kolomoets Elena, Armaroli Paola, Gallo Federica, Balsamo Antonella, Muto Giovanni, D'Urso Leonardo, Puppo Paolo, Naselli Angelo, Segnan Nereo, |
|
Are GSTM1, GSTT1 and CAG repeat length of androgen receptor gene polymorphisms associated with risk of prostate cancer in Iranian patients?
Pathology oncology research : POR 2011 Jun 17 (2): 269-75. Ashtiani Zahra Ousati, Hasheminasab Sayed-Mohammad, Ayati Mohsen, Goulian Bareto Sabah, Modarressi Mohammad Hosse |
|
Decision tree-based modeling of androgen pathway genes and prostate cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011 Jun 20 (6): 1146-55. Barnholtz-Sloan Jill S, Guan Xiaowei, Zeigler-Johnson Charnita, Meropol Neal J, Rebbeck Timothy |
|
Genotyping of sex hormone-related pathways in benign and malignant human prostate tissues: data of a preliminary study.
Omics : a journal of integrative biology 2011 Jun 15 (6): 369-74. Balistreri Carmela Rita, Caruso Calogero, Carruba Giuseppe, Miceli Vitale, Candore Giuseppi |
|
Variation in CAG and GGN repeat lengths and CAG/GGN haplotype in androgen receptor gene polymorphism and prostate carcinoma in Nigerians.
British journal of biomedical science 2011 68 (3): 138-42. Akinloye O, Gromoll J, Simoni |
|
Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trial.
The Journal of urology 2010 Dec 184 (6): 2297-302. Price Douglas K, Chau Cindy H, Till Cathee, Goodman Phyllis J, Baum Caitlin E, Ockers Sandy B, English Bevin C, Minasian Lori, Parnes Howard L, Hsing Ann W, Reichardt Juergen K V, Hoque Ashraful, Tangen Catherine M, Kristal Alan R, Thompson Ian M, Figg William |
|
Polymorphisms in the AR and PSA genes as markers of susceptibility and aggressiveness in prostate cancer.
Cancer investigation 2010 Nov 28 (9): 917-24. Kuasne Hellen, Rodrigues Iara Sant'Ana, Fuganti Paulo Emílio, Losi-Guembarovski Roberta, Ito Kazuhiro, Kishima Marina O, Rodrigues Marco Aurélio de Freitas, Rogatto Silvia Regina, Santos Rodrigo Mattos dos, Cólus Ilce Mara de Syll |
|
Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium.
Human molecular genetics 2010 Oct 19 (19): 3873-84. Canzian Federico, Cox David G, Setiawan V Wendy, Stram Daniel O, Ziegler Regina G, Dossus Laure, Beckmann Lars, Blanché Hélène, Barricarte Aurelio, Berg Christine D, Bingham Sheila, Buring Julie, Buys Saundra S, Calle Eugenia E, Chanock Stephen J, Clavel-Chapelon Françoise, DeLancey John Oliver L, Diver W Ryan, Dorronsoro Miren, Haiman Christopher A, Hallmans Göran, Hankinson Susan E, Hunter David J, Hüsing Anika, Isaacs Claudine, Khaw Kay-Tee, Kolonel Laurence N, Kraft Peter, Le Marchand Loïc, Lund Eiliv, Overvad Kim, Panico Salvatore, Peeters Petra H M, Pollak Michael, Thun Michael J, Tjønneland Anne, Trichopoulos Dimitrios, Tumino Rosario, Yeager Meredith, Hoover Robert N, Riboli Elio, Thomas Gilles, Henderson Brian E, Kaaks Rudolf, Feigelson Heather Spenc |
|
A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
The Journal of clinical endocrinology and metabolism 2010 Sep 95 (9): E121-7. Lindström Sara, Ma Jing, Altshuler David, Giovannucci Edward, Riboli Elio, Albanes Demetrius, Allen Naomi E, Berndt Sonja I, Boeing Heiner, Bueno-de-Mesquita H Bas, Chanock Stephen J, Dunning Alison M, Feigelson Heather Spencer, Gaziano J Michael, Haiman Christopher A, Hayes Richard B, Henderson Brian E, Hunter David J, Kaaks Rudolf, Kolonel Laurence N, Le Marchand Loic, Martínez Carmen, Overvad Kim, Siddiq Afshan, Stampfer Meir, Stattin Pär, Stram Daniel O, Thun Michael J, Trichopoulos Dimitrios, Tumino Rosario, Virtamo Jarmo, Weinstein Stephanie J, Yeager Meredith, Kraft Peter, Freedman Matthew |
|
Inherited variations in AR, ESR1, and ESR2 genes are not associated with prostate cancer aggressiveness or with efficacy of androgen deprivation therapy.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010 Jul 19 (7): 1871-8. Sun Tong, Lee Gwo-Shu Mary, Werner Lillian, Pomerantz Mark, Oh William K, Kantoff Philip W, Freedman Matthew |
|
Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3).
Human molecular genetics 2009 Oct 18 (19): 3749-57. Ahn Jiyoung, Schumacher Fredrick R, Berndt Sonja I, Pfeiffer Ruth, Albanes Demetrius, Andriole Gerald L, Ardanaz Eva, Boeing Heiner, Bueno-de-Mesquita Bas, Chanock Stephen J, Clavel-Chapelon Françoise, Diver W Ryan, Feigelson Heather Spencer, Gaziano J Michael, Giovannucci Edward, Haiman Christopher A, Henderson Brian E, Hoover Robert N, Kolonel Laurence N, Kraft Peter, Ma Jing, Le Marchand Loïc, Overvad Kim, Palli Domenico, Stattin Pär, Stampfer Meir, Stram Daniel O, Thomas Gilles, Thun Michael J, Travis Ruth C, Trichopoulos Dimitrios, Virtamo Jarmo, Weinstein Stephanie J, Yeager Meredith, Kaaks Rudolf, Hunter David J, Hayes Richard |
|
[A case-control study of environmental and genetic factors and prostate cancer in Guangdong].
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] 2009 Jul 43 (7): 581-5. Wu Yun-Jie, Liang Cai-Hua, Zhou Fang-Jian, Gao Xin, Chen Ling-Wu, Liu Qi |
|
Short alleles of both GGN and CAG repeats at the exon-1 of the androgen receptor gene are associated to increased PSA staining and a higher Gleason score in human prostatic cancer.
The Journal of steroid biochemistry and molecular biology 2009 Jan 113 (1-2): 85-91. Rodríguez-González Germán, Cabrera Saúl, Ramírez-Moreno Raquel, Bilbao Cristina, Díaz-Chico Juan C, Serra Lluis, Chesa Nicolás, Cabrera Juan J, Díaz-Chico B Nicol |
|
Joint effects of inflammation and androgen metabolism on prostate cancer severity.
International journal of cancer. Journal international du cancer 2008 Sep 123 (6): 1385-9. Rebbeck Timothy R, Rennert Hanna, Walker Amy H, Panossian Saarene, Tran Teo, Walker Kyle, Spangler Elaine, Patacsil-Coomes Margerie, Sachdeva Rajeev, Wein Alan J, Malkowicz S Bruce, Zeigler-Johnson Charni |
|
PSA and androgen-related gene (AR, CYP17, and CYP19) polymorphisms and the risk of adenocarcinoma at prostate biopsy.
DNA and cell biology 2008 Sep 27 (9): 497-503. dos Santos Rodrigo Mattos, de Jesus Carlos Márcio Nóbrega, Trindade Filho José Carlos Souza, Trindade José Carlos Souza, de Camargo João Lauro Viana, Rainho Cláudia Aparecida, Rogatto Silvia Regi |
|
Shorter CAG repeats in androgen receptor and non-GG genotypes in prostate-specific antigen loci are associated with decreased risk of benign prostatic hyperplasia and prostate cancer.
Cancer letters 2008 Sep 268 (2): 340-7. Das Kakoli, Cheah Peh Yean, Lim Pei Li, Zain Yasmin Bte Mohad, Stephanie Fook-Chong, Zhao Yi, Cheng Christopher, Lau Web |
|
Hormone receptor-related gene polymorphisms and prostate cancer risk in North Indian population.
Molecular and cellular biochemistry 2008 Jul 314 (1-2): 25-35. Onsory Khadijeh, Sobti R C, Al-Badran Adnan Issa, Watanabe Masatoshi, Shiraishi Taizo, Krishan Awtar, Mohan Harsh, Kaur Pushpind |
|
A multigenic approach to evaluating prostate cancer risk in a systematic replication study.
Cancer genetics and cytogenetics 2008 Jun 183 (2): 94-8. Hsu Fang-Chi, Lindström Sara, Sun Jielin, Wiklund Fredrik, Chen Shyh-Huei, Adami Hans-Olov, Turner Aubrey R, Liu Wennuan, Bälter Katarina, Kim Jin Woo, Stattin Pär, Chang Bao-Li, Isaacs William B, Xu Jianfeng, Grönberg Henrik, Zheng S Lil |
|
Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.
Cancer investigation 2008 Feb 26 (1): 74-80. Silva Neto Brasil, Koff Walter J, Biolchi Vanderlei, Brenner Cleber, Biolo Karlo D, Spritzer Poli Mara, Brum Ilma |
|
Polymorphisms in genes regulating androgen activity among prostate cancer low-risk Inuit men and high-risk Scandinavians.
International journal of andrology 2008 Feb 31 (1): 25-30. Giwercman Charlotte, Giwercman Aleksander, Pedersen Henning Sloth, Toft Gunnar, Lundin Kristina, Bonde Jens-Peter, Lundberg Giwercman Yvon |
|
The androgen receptor CAG and GGN repeat polymorphisms and prostate cancer susceptibility in African-American men: results from the Flint Men's Health Study.
Journal of human genetics 2008 53 (3): 220-6. Lange Ethan M, Sarma Aruna V, Ray Anna, Wang Yunfei, Ho Lindsey A, Anderson Sarah A, Cunningham Julie M, Cooney Kathleen |
|
Inherited variation in hormone-regulating genes and prostate cancer survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Sep 13 (17): 5156-61. Lindström Sara, Adami Hans-Olov, Bälter Katarina Augustsson, Xu Jianfeng, Zheng S Lilly, Stattin Pär, Grönberg Henrik, Wiklund Fredr |
|
Evaluation of genetic variations in the androgen and estrogen metabolic pathways as risk factors for sporadic and familial prostate cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007 May 16 (5): 969-78. Cunningham Julie M, Hebbring Scott J, McDonnell Shannon K, Cicek Mine S, Christensen G Bryce, Wang Liang, Jacobsen Steven J, Cerhan James R, Blute Michael L, Schaid Daniel J, Thibodeau Stephen |
|
Is there an inter-relationship between prostate specific antigen, kallikrein-2 and androgen receptor gene polymorphisms with risk of prostate cancer in north Indian population?
Steroids 2007 Apr 72 (4): 335-41. Mittal Rama D, Mishra Dhruva K, Thangaraj K, Singh Rajender, Mandhani An |
|
Androgen receptor mutations are associated with Gleason score in localized prostate cancer.
BJU international 2006 Dec 98 (6): 1320-5. Sanchez Daniel, Rosell David, Honorato Beatriz, Lopez Jorge, Arocena Juan, Sanz Gonza |
|
Androgen receptor and vitamin D receptor gene polymorphisms and prostate cancer risk.
European journal of cancer (Oxford, England : 1990) 2006 Nov 42 (16): 2833-7. Andersson Patiyan, Varenhorst Eberhard, Söderkvist Pet |
|
Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development.
Cancer research 2006 Nov 66 (22): 11077-83. Lindström Sara, Wiklund Fredrik, Adami Hans-Olov, Bälter Katarina Augustsson, Adolfsson Jan, Grönberg Henr |
|
Frequent finding of the androgen receptor A645D variant in normal population.
The Journal of clinical endocrinology and metabolism 2006 Aug 91 (8): 3228-31. Lundin Kristina B, Nordenskjöld Agneta, Giwercman Aleksander, Giwercman Yvonne |
|
Genetic Susceptibility to Prostate Cancer: Prostate-specific Antigen and its Interaction with the Androgen Receptor (United States).
Cancer causes & control : CCC 2006 Mar 17 (2): 187-97. Sieh Weiva, Edwards Karen L, Fitzpatrick Annette L, Srinouanprachanh Sengkeo L, Farin Fred M, Monks Stephanie A, Kronmal Richard A, Eaton David |
|
Association of the polymorphisms of genes involved in androgen metabolism and signaling pathways with familial prostate cancer risk in a Japanese population.
Cancer detection and prevention 2006 30 (3): 262-8. Okugi Hironobu, Nakazato Haruki, Matsui Hiroshi, Ohtake Nobuaki, Nakata Seiji, Suzuki Kazuhi |
|
GGN repeat length and GGN/CAG haplotype variations in the androgen receptor gene and prostate cancer risk in south Indian men.
Journal of human genetics 2006 51 (11): 998-1005. Vijayalakshmi Krishnaswamy, Thangaraj Kumarasamy, Rajender Singh, Vettriselvi Venkatesan, Venkatesan Perumal, Shroff Sunil, Vishwanathan K N, Paul Solomon F |
|
South Indian men with reduced CAG repeat length in the androgen receptor gene have an increased risk of prostate cancer.
Journal of human genetics 2006 51 (3): 254-7. Krishnaswamy Vijayalakshmi, Kumarasamy Thangaraj, Venkatesan Vettriselvi, Shroff Sunil, Jayanth Vikram R, Paul Solomon F |
|
Polymorphisms in the androgen receptor and the prostate-specific antigen genes and prostate cancer risk.
The Prostate 2005 Sep 65 (1): 58-65. Salinas Claudia A, Austin Melissa A, Ostrander Elaine O, Stanford Janet |
|
Somatic mosaicism and cancer: a micro-genetic examination into the role of the androgen receptor gene in prostate cancer.
Cancer research 2005 Sep 65 (18): 8514-8. Alvarado Carlos, Beitel Lenore K, Sircar Kanishka, Aprikian Armen, Trifiro Mark, Gottlieb Bru |
|
Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population?
Clinical genetics 2005 Jul 68 (1): 55-60. Mishra Dk, Thangaraj K, Mandhani A, Kumar A, Mittal |
|
Polymorphic forms of prostate specific antigen and their interaction with androgen receptor trinucleotide repeats in prostate cancer.
The Prostate 2005 Jun 63 (4): 309-15. Binnie Margaret C, Alexander Freda E, Heald Charlotte, Habib Fouad |
|
CYP3A43 Pro(340)Ala polymorphism and prostate cancer risk in African Americans and Caucasians.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 May 14 (5): 1257-61. Stone Angie, Ratnasinghe Luke D, Emerson Ginny L, Modali Rama, Lehman Terri, Runnells Gail, Carroll Alindria, Carter Weleetka, Barnhart Samuel, Rasheed Al A, Greene Graham, Johnson Don E, Ambrosone Christine B, Kadlubar Fred F, Lang Nicholas |
|
Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 May 14 (5): 1262-9. Platz Elizabeth A, Leitzmann Michael F, Rifai Nader, Kantoff Philip W, Chen Yen-Ching, Stampfer Meir J, Willett Walter C, Giovannucci Edwa |
|
CAG polymorphic repeat length in androgen receptor gene combined with pretreatment serum testosterone level as prognostic factor in patients with metastatic prostate cancer.
European urology 2005 Apr 47 (4): 557-63. Shimbo Masaki, Suzuki Hiroyoshi, Kamiya Naoto, Imamoto Takashi, Komiya Akira, Ueda Takeshi, Watanabe Masatoshi, Shiraishi Taizo, Ichikawa Tomohi |
|
The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 Apr 14 (4): 993-6. Hayes Vanessa M, Severi Gianluca, Eggleton Sarah A, Padilla Emma J D, Southey Melissa C, Sutherland Robert L, Hopper John L, Giles Graham |
|
The impact of CAG repeats in exon 1 of the androgen receptor on disease progression after prostatectomy.
Cancer 2005 Feb 103 (3): 528-37. Powell Isaac J, Land Susan J, Dey Jyotirmoy, Heilbrun Lance K, Hughes Mark R, Sakr Wael, Everson Richard |
|
Systematic evaluation of genetic variation at the androgen receptor locus and risk of prostate cancer in a multiethnic cohort study.
American journal of human genetics 2005 Jan 76 (1): 82-90. Freedman Matthew L, Pearce Celeste L, Penney Kathryn L, Hirschhorn Joel N, Kolonel Laurence N, Henderson Brian E, Altshuler Dav |
|
Association between hormonal genetic polymorphisms and early-onset prostate cancer.
Prostate cancer and prostatic diseases 2005 8 (1): 95-102. Forrest M S, Edwards S M, Houlston R, Kote-Jarai Z, Key T, Allen N, Knowles M A, Turner F, Ardern-Jones A, Murkin A, Williams S, Oram R, Bishop D T, Eeles R A, |
|
The relationship between the androgen receptor CAG repeat polymorphism length and the response to intermittent androgen suppression therapy for advanced prostate cancer.
Prostate cancer and prostatic diseases 2005 8 (2): 179-83. Klotz L, Correia A, Zhang |
|
How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk?
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004 Nov 13 (11 Pt 1): 1765-71. Zeegers Maurice P, Kiemeney Lambertus A L M, Nieder Alan M, Ostrer Har |
|
Differences in ornithine decarboxylase and androgen receptor allele frequencies among ethnic groups.
Molecular carcinogenesis 2004 Oct 41 (2): 120-123. O'Brien Thomas G, Guo Y, Visvanathan K, Sciulli J, McLaine M, Helzlsouer K J, Watkins-Bruner |
|
Absence of a correlation of androgen receptor gene CAG repeat length and prostate cancer risk in an African-American population.
Clinical prostate cancer 2004 Sep 3 (2): 98-103. Gilligan Timothy, Manola Judith, Sartor Oliver, Weinrich Sally P, Moul Judd W, Kantoff Philip |
|
Androgen receptor polymorphisms and risk of biochemical failure among prostatectomy patients.
The Prostate 2004 Sep 60 (4): 343-51. Strom Sara S, Gu Yun, Zhang Hui, Troncoso Patricia, Babaian Richard J, Pettaway Curtis A, Shete Sanjay, Spitz Margaret R, Logothetis Christopher |
|
Androgen receptor CAG repeat length correlates with semen PSA levels in adolescence.
The Prostate 2004 May 59 (3): 227-33. Giwercman Yvonne Lundberg, Richthoff Jonas, Lilja Hans, Anderberg Camilla, Abrahamsson Per-Anders, Giwercman Aleksand |
|
[Genetic risk factors of prostate cancer in Han nationality population in Northern China and a preliminary study of the reason of racial difference in prevalence of prostate cancer]
Zhonghua yi xue za zhi 2004 Mar 84 (5): 364-8. Liu JH, Li HW, Tong M, Li M, Na YQ |
|
Association among an ornithine decarboxylase polymorphism, androgen receptor gene (CAG) repeat length and prostate cancer risk.
The Journal of urology 2004 Feb 171 (2 Pt 1): 652-5. Visvanathan Kala, Helzlsouer Kathy J, Boorman David W, Strickland Paul T, Hoffman Sandy C, Comstock George W, O'Brien Thomas G, Guo Yongj |
|
Androgen receptor gene polymorphism and prostate cancer in Taiwan.
Journal of the Formosan Medical Association = Taiwan yi zhi 2003 Oct 102 (10): 680-6. Huang Shu-Pin, Chou Yii-Her, Chang Wun-Shaing Wayne, Wu Ming-Tsang, Yu Chia-Cheng, Wu TonyT, Lee Ying-Huei, Huang Jong-Khing, Wu Wen-Jeng, Huang Chun-Hsiu |
|
Associations of serum testosterone with microvessel density, androgen receptor density and androgen receptor gene polymorphism in prostate cancer.
The Journal of urology 2003 Apr 169 (4): 1312-5. Schatzl Georg, Madersbacher Stephan, Haitel Andrea, Gsur Andrea, Preyer Martin, Haidinger Gerald, Gassner Christa, Ochsner Michaela, Marberger Micha |
|
Difference between Swedish and Japanese men in the association between AR CAG repeats and prostate cancer suggesting a susceptibility-modifying locus overlapping the androgen receptor gene.
International journal of molecular medicine 2003 Apr 11 (4): 529-33. Li Chunde, Grönberg Henrik, Matsuyama Hideyasu, Weber Günther, Nordenskjöld Magnus, Naito Katsusuke, Bergh Anders, Bergerheim Ulf, Damber Jan-Erik, Larsson Catharina, Ekman Pet |
|
Steroid hormone genotypes ARStuI and ER325 are linked to the progression of human prostate cancer.
Cancer genetics and cytogenetics 2003 Mar 141 (2): 91-6. Medeiros Rui, Vasconcelos André, Costa Sandra, Pinto Daniela, Morais Antonio, Oliveira Jorge, Lopees Carl |
|
Androgen receptor gene alterations in Finnish male breast cancer.
Breast cancer research and treatment 2003 Jan 77 (2): 167-70. Syrjäkoski Kirsi, Hyytinen Eija-R, Kuukasjärvi Tuula, Auvinen Anssi, Kallioniemi Olli-P, Kainu Tommi, Koivisto Pasi |
|
Androgen receptor CAG repeat polymorphism in prostate cancer from a Brazilian population.
Cancer detection and prevention 2003 27 (5): 321-6. Santos Mariana L dos, Sarkis Alvaro S, Nishimoto Inês N, Nagai Maria |
|
The androgen receptor CAG repeat and prostate cancer risk.
Methods in molecular medicine 2003 81 (): 255-66. Clark Peter E, Irvine Ryan A, Coetzee Gerhard |
|
Androgen receptor length polymorphism associated with prostate cancer risk in Hispanic men.
The Journal of urology 2002 Nov 168 (5): 2245-8. Balic Ivana, Graham Stanley T, Troyer Dean A, Higgins Betsy A, Pollock Brad H, Johnson-Pais Teresa L, Thompson Ian M, Leach Robin |
|
Androgen receptor polymorphisms and the incidence of prostate cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002 Oct 11 (10 Pt 1): 1033-40. Chen Chu, Lamharzi Najib, Weiss Noel S, Etzioni Ruth, Dightman Douglas A, Barnett Matt, DiTommaso Dante, Goodman Ga |
|
The CAG trinucleotide repeat length in the androgen receptor does not predict the early onset of prostate cancer.
BJU international 2002 Oct 90 (6): 573-8. Mir K, Edwards J, Paterson P J, Hehir M, Underwood M A, Bartlett J M |
|
Racial variation in CAG repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002 Sep 20 (17): 3599-604. Bennett Charles L, Price Douglas K, Kim Simon, Liu Dachao, Jovanovic Borko D, Nathan Derek, Johnson Margaret E, Montgomery Jeffrey S, Cude Kelly, Brockbank Justin C, Sartor Oliver, Figg William |
|
Androgen receptor CAG polymorphism and prostate cancer risk.
Human genetics 2002 Aug 111 (2): 166-71. Mononen Nina, Ikonen Tarja, Autio Ville, Rökman Annika, Matikainen Mika P, Tammela Teuvo L J, Kallioniemi Olli-P, Koivisto Pasi A, Schleutker Johan |
|
Association studies of serum prostate-specific antigen levels and the genetic polymorphisms at the androgen receptor and prostate-specific antigen genes.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002 Jul 11 (7): 664-9. Xu Jianfeng, Meyers Deborah A, Sterling David A, Zheng Siqun L, Catalona William J, Cramer Scott D, Bleecker Eugene R, Ohar Ji |
|
CAG polymorphic repeat lengths in androgen receptor gene among Japanese prostate cancer patients: potential predictor of prognosis after endocrine therapy.
The Prostate 2002 May 51 (3): 219-24. Suzuki Hiroyoshi, Akakura Koichiro, Komiya Akira, Ueda Takeshi, Imamoto Takashi, Furuya Yuzo, Ichikawa Tomohiko, Watanabe Masatoshi, Shiraishi Taizo, Ito Har |
|
Allelic frequencies of six polymorphic markers for risk of prostate cancer.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica ... [et al.] 2002 Feb 35 (2): 205-13. Ribeiro M L, Santos A, Carvalho-Salles A B, Hackel |
|
Polymorphic GGC repeats in the androgen receptor gene are associated with hereditary and sporadic prostate cancer risk.
Human genetics 2002 Feb 110 (2): 122-9. Chang Bao-li, Zheng Siqun L, Hawkins Gregory A, Isaacs Sarah D, Wiley Kathy E, Turner Aubrey, Carpten John D, Bleecker Eugene R, Walsh Patrick C, Trent Jeffrey M, Meyers Deborah A, Isaacs William B, Xu Jianfe |
|
The role of an androgen receptor polymorphism in the clinical outcome of patients with metastatic prostate cancer.
Urologia internationalis 2002 68 (1): 16-23. Cude Kelly J, Montgomery Jeffrey S, Price Douglas K, Dixon Shannon C, Kincaid Randall L, Kovacs Karl F, Venzon David J, Liewehr David J, Johnson Margaret E, Reed Eddie, Figg William |
- Page last reviewed:Mar 16, 2019
- Page last updated:Jun 03, 2020
- Content source: